-
1
-
-
0010589901
-
-
1 Commission on Anaesthetics. Lancet 1893; i: 629-38.
-
(1893)
Lancet
, vol.1
, pp. 629-638
-
-
-
2
-
-
0028893733
-
Pharmacovigilance: Paradise lost, regained or postponed?
-
2 Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? J R Coll Physicians Lond 1995; 29: 41-49.
-
(1995)
J R Coll Physicians Lond
, vol.29
, pp. 41-49
-
-
Rawlins, M.D.1
-
4
-
-
84942481986
-
Pathogenic effects of elixir of sulfanilamide (diethylene glycol) poisoning
-
4 Geiling EMK, Cannon PR. Pathogenic effects of elixir of sulfanilamide (diethylene glycol) poisoning. JAMA 1938; iii: 919.
-
(1938)
JAMA
, vol.3
, pp. 919
-
-
Geiling, E.M.K.1
Cannon, P.R.2
-
5
-
-
47349113508
-
Thalidomide and congenital abnormalities
-
5 McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; ii: 1358.
-
(1961)
Lancet
, vol.2
, pp. 1358
-
-
McBride, W.G.1
-
6
-
-
73849164353
-
A study of the german outbreak of phocomelia
-
6 Taussig HB. A study of the German outbreak of phocomelia. JAMA 1963; 180: 1106-14.
-
(1963)
JAMA
, vol.180
, pp. 1106-1114
-
-
Taussig, H.B.1
-
7
-
-
0017408889
-
Frequency of eye complaints and rashes among patients receiving practolol and propranolol
-
7 Skegg DCG, Doll R. Frequency of eye complaints and rashes among patients receiving practolol and propranolol. Lancet 1977; ii: 475-78.
-
(1977)
Lancet
, vol.2
, pp. 475-478
-
-
Skegg, D.C.G.1
Doll, R.2
-
8
-
-
0017732474
-
The case for recording events in clinical trials
-
8 Skegg DCG, Doll R. The case for recording events in clinical trials. BMJ 1977 b; 2; 1523-24.
-
(1977)
BMJ
, vol.2
, pp. 1523-1524
-
-
Skegg, D.C.G.1
Doll, R.2
-
9
-
-
0001904623
-
The yellow card data: The nature and scale of the adverse drug reactions problem
-
Mann RD, ed. Carnforth: Parthenon Publishing
-
9 Mann RD. The yellow card data: the nature and scale of the adverse drug reactions problem. In: Mann RD, ed. Adverse drug reactions: the scale and nature of the problem and the way forward. Carnforth: Parthenon Publishing, 1987: 5-66.
-
(1987)
Adverse Drug Reactions: the Scale and Nature of the Problem and the Way Forward
, pp. 5-66
-
-
Mann, R.D.1
-
10
-
-
0001278619
-
Phenethyldiguanide: A dangerous side-effect
-
10 Walker RS, Linton AL. Phenethyldiguanide: a dangerous side-effect. BMJ 1959; 2: 1005-06.
-
(1959)
BMJ
, vol.2
, pp. 1005-1006
-
-
Walker, R.S.1
Linton, A.L.2
-
11
-
-
0028817865
-
Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis b
-
11 McKenzie R, Fried MW, Sallie R, et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995; 333: 1099-105.
-
(1995)
N Engl J Med
, vol.333
, pp. 1099-1105
-
-
McKenzie, R.1
Fried, M.W.2
Sallie, R.3
-
12
-
-
0031566849
-
Communicating drug-safety information
-
12 McNamee D. Communicating drug-safety information. Lancet 1997; 350: 1646.
-
(1997)
Lancet
, vol.350
, pp. 1646
-
-
McNamee, D.1
|